New drug formulations of colony-stimulating factors in oncohematology

New drug formulations of colony-stimulating factors in oncohematology

The use of colony-stimulating factors became an autonomous approach in complex supportive care of blood tumors. By indications of granulocyte colony-stimulating factor (G-CSF) it is possible to reduce of neutropenic period, perform an optimal timing of therapy, decrease a number of infection complic...

Full description

Bibliographic Details
Main Authors:	T. T. Valiev, R. R. Fatkhullin, Yu. E. Ryabukhina, P. A. Zeynalova
Format:	Article
Language:	Russian
Published:	ABV-press 2023-03-01
Series:	Онкогематология
Subjects:	leukemia lymphoma supportive care colony-stimulating factor pegfilgrastim
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/805

Similar Items

Acute methotrexate toxicity managed with leucovorin and pegylated granulocyte colony-stimulating factor: A report of two cases and review of literature
by: Shiva Shankar Marri, et al.
Published: (2024-01-01)

Granulocyte-colony stimulating factor-associated aortitis in cancer: A systematic literature review
by: Hideko Hoshina, et al.
Published: (2021-01-01)

Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
by: Nana Matsumoto, et al.
Published: (2022-08-01)

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography revealed the course of granulocyte-colony stimulating factor-associated aortitis: A case report
by: Yoichiro Hijikata, MD, et al.
Published: (2024-09-01)

Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report
by: Yurie Seto, et al.
Published: (2023-09-01)

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study
by: Derek Weycker, et al.
Published: (2019-08-01)

Mecapegfilgrastim for prophylaxis of febrile neutropenia in children and adolescents with rhabdomyosarcoma or Ewing sarcoma: a prospective, single-arm, pilot study
by: Wen Zhao, et al.
Published: (2024-08-01)

Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature
by: Yukiko Seto, et al.
Published: (2022-08-01)

Health professionals’ preferences with the use of pegfilgrastim on-body injector at oncology centers in 8 cities in Colombia
by: María Alejandra Larrarte-González, et al.
Published: (2023-05-01)

Microarrays: a new era in development of oncohematology
by: Ye. A. Nikitin, et al.
Published: (2022-11-01)

Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)

Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)

Possibilities of Predicting Methotrexate-associated Toxicity in Oncohematology Based on Molecular Genetic Testing Methods
by: Zarui K. Simavonyan, et al.
Published: (2024-11-01)

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
by: Guariglia R, et al.
Published: (2016-01-01)

Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis
by: Shruti Rastogi, et al.
Published: (2021-10-01)

Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic
by: Wei C, et al.
Published: (2021-04-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)

A case of granulocyte colony-stimulating factor producing lung adenocarcinoma with anaplastic lymphoma kinase gene rearrangements
by: Keum-Ju Choi, et al.
Published: (2023-01-01)

Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib
by: Baijun Fang, et al.
Published: (2011-04-01)

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study
by: Patrick Wayne Cobb, et al.
Published: (2020-09-01)

Oncohematologic diseases and rheumatic disorders
by: Nelson Hamerschlak
Published: (2008-03-01)

Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis
by: Giniatullina Raisa, et al.
Published: (2011-06-01)

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
by: Girma Tekle Gebremariam, et al.
Published: (2022-12-01)

Myeloid Colony Stimulating Factors as Regulators of Macrophage Polarization
by: Thomas A Hamilton
Published: (2014-11-01)

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors
by: Elina Kaprio, et al.
Published: (2024-01-01)

Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
by: Ga-Young Song, et al.
Published: (2023-10-01)

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
by: Youngwoo Jeon, et al.
Published: (2023-03-01)

High-doses Granulocyte Colony-stimulating Factor (G-CSF) Benefit Elderly Patients with Acute Myeloid Leukemia
by: LI Wei, et al.
Published: (2018-05-01)

The clinical impact of primary granulocyte-colony stimulating factor prophylaxis in children with acute lymphoblastic leukemia who underwent induction chemotherapy
by: Yi-An Lu, et al.
Published: (2024-12-01)

Saharan dust induces the lung disease-related cytokines granulocyte–macrophage colony-stimulating factor and granulocyte colony-stimulating factor
by: Gerrit Bredeck, et al.
Published: (2024-04-01)

Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
by: Vineet Talwar, et al.
Published: (2017-01-01)

Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study
by: Barbara Loteta, et al.
Published: (2024-07-01)

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
by: William F Jiemy, et al.
Published: (2020-01-01)

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
by: Kristine Yttersian Sletta, et al.
Published: (2021-03-01)

Effect of exogenous Granulocyte Colony-Stimulating Factor on ovulation and pregnancy rate in NMRI mice
by: F Golshan, et al.
Published: (2017-05-01)

Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab
by: Huohuan Tian, et al.
Published: (2023-01-01)

Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
by: Ryota Morinaga, et al.
Published: (2019-08-01)

Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers
by: Audrius Sveikata, et al.
Published: (2014-01-01)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
by: Kosuke Hamai, et al.
Published: (2023-04-01)

Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis
by: Giovanni Rosti, et al.
Published: (2011-09-01)